The Covid Inquiry Podcast: ‘I wasn’t the decision maker’
The Inquiry hears from the lead of the test and trace unit
another news portal
The Inquiry hears from the lead of the test and trace unit
A new award will help early-career researchers who study dystonia, the Michael J. Fox Foundation announced Tuesday. The award is $150,000 for two years.
A long-studied metabolic hormone, FGF21, also acts as a stress hormone—a discovery that helps explain how psychological stress causes metabolic dysregulation and drives physical disease
Eating peppermints can increase alertness in people who are ill with the common cold, according to new research by Cardiff University scientists.
South Africa’s health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a “groundbreaking” tool against the disease
One in eight men will be diagnosed with prostate cancer in their lifetime.
A peer-reviewed viewpoint article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for treating stress-related psychiatric
Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world’s deadliest cancers.
Discover how Thermo Fisher’s handheld Raman and lab FTIR tools are transforming controlled substance testing with safer, faster, and more reliable results.
California this week plans to notify Affordable Care Act marketplace enrollees that their costs could rise sharply next year unless Congress extends subsidies to help
Cremation has become Americans’ most popular choice for the postmortem treatment of their bodies. But the process involves burning fossil fuels, which may release toxic
Ronald Klein was biking around his neighborhood in North Wales, Pennsylvania, in 2006 and tried to jump a curb. “But I was going too slow
Researchers led by Dr. Roberto Goya-Maldonado at the University Medical Center Göttingen have identified a rapid physiological marker that predicts which patients with major depression
In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Bruce M. Cohen discusses results and insights that are reshaping international approaches to